Naiditch H, Betts M, Larman H, Levi M, Rosenberg A
Front Immunol. 2025; 15:1376654.
PMID: 40012912
PMC: 11861071.
DOI: 10.3389/fimmu.2024.1376654.
Jandosov J, Berillo D, Misra A, Alavijeh M, Chenchik D, Baimenov A
Int J Mol Sci. 2025; 26(3).
PMID: 39940720
PMC: 11817206.
DOI: 10.3390/ijms26030952.
Leite G, Sousa M, Rodrigues L, Brunialti M, Medina-Pestana J, Butler J
Front Immunol. 2024; 15:1508110.
PMID: 39737170
PMC: 11683116.
DOI: 10.3389/fimmu.2024.1508110.
Fallah A, Sedighian H, Kachuei R, Fooladi A
Curr Res Microb Sci. 2024; 8:100324.
PMID: 39717208
PMC: 11665312.
DOI: 10.1016/j.crmicr.2024.100324.
Silva R
Biogerontology. 2024; 26(1):17.
PMID: 39621124
DOI: 10.1007/s10522-024-10152-4.
The impact of cryopreservation on cytokine secretion and polyfunctionality in human PBMCs: a comparative study.
Linder A, Portmann K, Eyer K
Front Immunol. 2024; 15:1478311.
PMID: 39434875
PMC: 11491348.
DOI: 10.3389/fimmu.2024.1478311.
Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control.
Wang S, Li W, Wang Z, Yang W, Li E, Xia X
Signal Transduct Target Ther. 2024; 9(1):223.
PMID: 39256346
PMC: 11412324.
DOI: 10.1038/s41392-024-01917-x.
Current treatment of Psoriasis triggered by Cytokine Storm and future immunomodulation strategies.
Braga G, Francisco G, Bagatini M
J Mol Med (Berl). 2024; 102(10):1187-1198.
PMID: 39212718
DOI: 10.1007/s00109-024-02481-1.
JAK Inhibitors in Cytokine Storm Syndromes.
Keenan C, Albeituni S, Nichols K, Hines M
Adv Exp Med Biol. 2024; 1448:583-600.
PMID: 39117841
DOI: 10.1007/978-3-031-59815-9_39.
IL-1 Family Blockade in Cytokine Storm Syndromes.
Cron R
Adv Exp Med Biol. 2024; 1448:553-563.
PMID: 39117838
DOI: 10.1007/978-3-031-59815-9_36.
Systemic Lupus Erythematosus and Cytokine Storm.
Caricchio R, Gallucci S
Adv Exp Med Biol. 2024; 1448:355-364.
PMID: 39117826
DOI: 10.1007/978-3-031-59815-9_24.
Persistent alterations in gray matter in COVID-19 patients experiencing sleep disturbances: a 3-month longitudinal study.
Zhou K, Duan G, Liu Y, Peng B, Zhou X, Qin L
Neural Regen Res. 2024; 20(10):3013-3024.
PMID: 38934390
PMC: 11826451.
DOI: 10.4103/NRR.NRR-D-23-01651.
A Novel Drug Candidate for Sepsis Targeting Heparanase by Inhibiting Cytokine Storm.
Wang D, Wang K, Liu Q, Liu M, Zhang G, Feng K
Adv Sci (Weinh). 2024; 11(29):e2403337.
PMID: 38810101
PMC: 11304236.
DOI: 10.1002/advs.202403337.
Early sevoflurane sedation in severe COVID-19-related lung injury patients. A pilot randomized controlled trial.
Beck-Schimmer B, Schadde E, Pietsch U, Filipovic M, Dubendorfer-Dalbert S, Fodor P
Ann Intensive Care. 2024; 14(1):41.
PMID: 38536545
PMC: 10973324.
DOI: 10.1186/s13613-024-01276-4.
A living neutrophil Biorobot synergistically blocks multifaceted inflammatory pathways in macrophages to effectively neutralize cytokine storm.
Gao Y, Zhou A, Chen K, Zhou X, Xu Y, Wu S
Chem Sci. 2024; 15(6):2243-2256.
PMID: 38332816
PMC: 10848682.
DOI: 10.1039/d3sc03438k.
AC-73 and Syrosingopine Inhibit SARS-CoV-2 Entry into Megakaryocytes by Targeting CD147 and MCT4.
Spinello I, Saulle E, Quaranta M, Pelosi E, Castelli G, Cerio A
Viruses. 2024; 16(1).
PMID: 38257782
PMC: 10818282.
DOI: 10.3390/v16010082.
Integrin β Expression as a New Diagnostic Marker for Arteriovenous Thrombosis: A Single-Center Prospective Study.
Xi Y, Mao Y, Yang F, Xi P, Zhu W, Song Y
J Cardiovasc Dev Dis. 2023; 10(11).
PMID: 37998519
PMC: 10672679.
DOI: 10.3390/jcdd10110461.
γδ T cells: origin and fate, subsets, diseases and immunotherapy.
Hu Y, Hu Q, Li Y, Lu L, Xiang Z, Yin Z
Signal Transduct Target Ther. 2023; 8(1):434.
PMID: 37989744
PMC: 10663641.
DOI: 10.1038/s41392-023-01653-8.
Prediction of Survival by IL-6 in a Randomized Placebo-Controlled Trial of Anakinra in COVID-19 Cytokine Storm.
Jackson L, Khullar N, Beukelman T, Chapleau C, Kamath A, Cron R
Viruses. 2023; 15(10).
PMID: 37896812
PMC: 10612044.
DOI: 10.3390/v15102036.
Gut-brain pathogenesis of post-acute COVID-19 neurocognitive symptoms.
Plummer A, Matos Y, Lin H, Ryman S, Birg A, Quinn D
Front Neurosci. 2023; 17:1232480.
PMID: 37841680
PMC: 10568482.
DOI: 10.3389/fnins.2023.1232480.
